Company: NEWTP
Filing Date: 2025-06-06
Form Type: 424B5
Source: 0001587987-25-000104
Chunk: 9

Company: NewtekOne, Inc.
Filing Date: 2025-06-06
Form: 424B5
Chunk 9
---
</div>

### USE OF PROCEEDS
We may issue and sell up to 5,000,000 shares of our common stock of from time to time. Because there is no minimum offering amount required as a condition to this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this time. We estimate that the net proceeds from the sale of the shares of common stock that we are offering may be up to approximately $40,198,540 (based on an assumed offering price of $10.57 per share, the last reported sale price per share of our common stock on June 5, 2025) after deducting the Placement Agents’ commission and estimated offering expenses payable by us and taking into account that 1,100,000 million shares of our common stock have been previously sold pursuant to the 2023 Equity Distribution Agreement and the prospectus supplement, with an additional 3,900,000 million shares of our common stock remaining available to be sold from and including the date hereof under the Amended and Restated Equity Distribution Agreement and the prospectus supplement, as amended by this amendment.

We expect to use the proceeds that we receive from this offering for general corporate purposes. As of the date of this amendment, we cannot specify the particular uses, and the respective amounts we may allocate to those uses, for any net proceeds we receive. Accordingly, we will retain broad discretion over the use of these proceeds.

<div align='center'>S-6</div>

### CAPITALIZATION
The Amended and Restated Equity Distribution Agreement provides that we may offer and sell up to 5,000,000 shares of our common stock from time to time through the Placement Agents for the offer and sale of such common stock. The table below assumes that we will sell all of the 3,900,000 shares of common stock remaining available under the Amended and Restated Equity Distribution Agreement at a price of $10.57 per share (the last reported sale price per share of our common stock on June 5, 2025) but there is no guarantee that there will be any sales of our common stock pursuant to the Amended and Restated Equity Distribution Agreement, the prospectus supplement, as amended by this amendment and the accompanying prospectus. Actual sales, if any, of our common stock under the Amended and Restated Equity Distribution Agreement, the prospectus supplement, as amended by this amendment and the accompanying prospectus may be less than as